Murashige, D., C. Jang, M. Neinast, J.J. Edwards, A. Cowan, M.C. Hyman, et al. 2020. Comprehensive quantification of fuel use by the failing and nonfailing human heart. Science (New York, NY). 370 (6514): 364–368.

Article  CAS  Google Scholar 

Taleb, S. 2019. Tryptophan dietary impacts gut barrier and metabolic diseases. Frontiers in Immunology 10: 2113.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mangge, H., I. Stelzer, E.Z. Reininghaus, D. Weghuber, T.T. Postolache, and D. Fuchs. 2014. Disturbed tryptophan metabolism in cardiovascular disease. Current Medicinal Chemistry 21 (17): 1931–1937.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schrocksnadel, K., B. Wirleitner, C. Winkler, and D. Fuchs. 2006. Monitoring tryptophan metabolism in chronic immune activation. Clinica Chimica Acta 364 (1–2): 82–90.

Article  Google Scholar 

Lund, A., J.E. Nordrehaug, G. Slettom, S.H. Solvang, E.K. Pedersen, Ø. Midttun, et al. 2020. Plasma kynurenines and prognosis in patients with heart failure. PLoS ONE 15 (1): e0227365.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, Y., J. Song, K. Yu, D. Nie, C. Zhao, L. Jiao, et al. 2023. Indoleamine 2,3-dioxygenase 1 deletion-mediated kynurenine insufficiency inhibits pathological cardiac hypertrophy. Hypertension 80 (10): 2099–2111.

Article  CAS  PubMed  Google Scholar 

Laurans, L., N. Venteclef, Y. Haddad, M. Chajadine, F. Alzaid, S. Metghalchi, et al. 2018. Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health. Nature Medicine. 24 (8): 1113–1120.

Article  CAS  PubMed  Google Scholar 

Cole, J.E., N. Astola, A.P. Cribbs, M.E. Goddard, I. Park, P. Green, et al. 2015. Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development. Proceedings of the National Academy of Sciences United States of America 112 (42): 13033–13038.

Article  CAS  Google Scholar 

Yun, T.J., J.S. Lee, K. Machmach, D. Shim, J. Choi, Y.J. Wi, et al. 2016. Indoleamine 2,3-dioxygenase-expressing aortic plasmacytoid dendritic cells protect against atherosclerosis by induction of regulatory T cells. Cell Metabolism. 24 (6): 886.

Article  CAS  PubMed  Google Scholar 

Xue, C., G. Li, Q. Zheng, X. Gu, Q. Shi, Y. Su, et al. 2023. Tryptophan metabolism in health and disease. Cell Metabolism. 35 (8): 1304–1326.

Article  CAS  PubMed  Google Scholar 

Yan, J., K. Kothur, S. Mohammad, J. Chung, S. Patel, H.F. Jones, et al. 2023. CSF neopterin, quinolinic acid and kynurenine/tryptophan ratio are biomarkers of active neuroinflammation. eBioMedicine 91: 104589.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Queiroz, R.F., C.P. Stanley, K. Wolhuter, S.M.Y. Kong, R. Rajivan, N. McKinnon, et al. 2021. Hydrogen peroxide signaling via its transformation to a stereospecific alkyl hydroperoxide that escapes reductive inactivation. Nature Communications. 12 (1): 6626.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pires, A.S., G. Sundaram, B. Heng, S. Krishnamurthy, B.J. Brew, and G.J. Guillemin. 2022. Recent advances in clinical trials targeting the kynurenine pathway. Pharmacology & Therapeutics. 236: 108055.

Article  CAS  Google Scholar 

Zakharia Y., R.R. McWilliams, O. Rixe, J. Drabick, M.F. Shaheen, K.F. Grossmann, et al. 2021. Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma. Journal for Immunotherapy of Cancer 9(6): e002057. https://doi.org/10.1136/jitc-2020-002057.

Burger, P.M., S. Koudstaal, A. Mosterd, A.T.L. Fiolet, M. Teraa, M.G. van der Meer, et al. 2023. C-reactive protein and risk of incident heart failure in patients with cardiovascular disease. Journal of the American College of Cardiology. 82 (5): 414–426.

Article  CAS  PubMed  Google Scholar 

Hunt, S.A., W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, T.G. Ganiats, et al. 2009. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119 (14): e391-479.

PubMed  Google Scholar 

Miller, L., E. Birks, M. Guglin, H. Lamba, and O.H. Frazier. 2019. Use of ventricular assist devices and heart transplantation for advanced heart failure. Circulation Research 124 (11): 1658–1678.

Article  CAS  PubMed  Google Scholar 

Yuan, M., S.B. Breitkopf, X. Yang, and J.M. Asara. 2012. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nature Protocols. 7 (5): 872–881.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rebnord, E.W., E. Strand, Ø. Midttun, G.F.T. Svingen, M.H.E. Christensen, P.M. Ueland, et al. 2017. The kynurenine:Tryptophan ratio as a predictor of incident type 2 diabetes mellitus in individuals with coronary artery disease. Diabetologia 60 (9): 1712–1721.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Theiler-Schwetz V, C. Trummer, M.R. Grubler, M.H. Keppel, A. Zittermann, A. Tomaschitz, et al. 2023. Associations of parameters of the tryptophan-kynurenine pathway with cardiovascular risk factors in hypertensive patients. Nutrients 15(2):256. https://doi.org/10.3390/nu15020256.

Melhem, N.J., M. Chajadine, I. Gomez, K.Y. Howangyin, M. Bouvet, C. Knosp, et al. 2021. Endothelial cell indoleamine 2, 3-dioxygenase 1 alters cardiac function after myocardial infarction through kynurenine. Circulation 143 (6): 566–580.

Article  CAS  PubMed  Google Scholar 

Dschietzig, T.B., K.H. Kellner, K. Sasse, F. Boschann, R. Klusener, J. Ruppert, et al. 2019. Plasma kynurenine predicts severity and complications of heart failure and associates with established biochemical and clinical markers of disease. Kidney & Blood Pressure Research 44 (4): 765–776.

Article  CAS  Google Scholar 

Murphy, S.P., R. Kakkar, C.P. McCarthy, and J.L. Januzzi Jr. 2020. Inflammation in heart failure: JACC state-of-the-art review. Journal of the American College of Cardiology 75 (11): 1324–1340.

Article  PubMed  Google Scholar 

Anand, I.S., R. Latini, V.G. Florea, M.A. Kuskowski, T. Rector, S. Masson, et al. 2005. C-reactive protein in heart failure: Prognostic value and the effect of valsartan. Circulation 112 (10): 1428–1434.

Article  CAS  PubMed  Google Scholar 

Koller, L., M. Kleber, G. Goliasch, P. Sulzgruber, H. Scharnagl, G. Silbernagel, et al. 2014. C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction. European Journal of Heart Failure 16 (7): 758–766.

Article  CAS  PubMed  Google Scholar 

Cainzos-Achirica, M., C. Enjuanes, P. Greenland, J.W. McEvoy, M. Cushman, Z. Dardari, et al. 2018. The prognostic value of interleukin 6 in multiple chronic diseases and all-cause death: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 278: 217–225.

Article  CAS  PubMed  Google Scholar 

Wirleitner, B., V. Rudzite, G. Neurauter, C. Murr, U. Kalnins, A. Erglis, et al. 2003. Immune activation and degradation of tryptophan in coronary heart disease. European Journal of Clinical Investigation 33 (7): 550–554.

Article  CAS  PubMed  Google Scholar 

Kwidzinski, E., J. Bunse, O. Aktas, D. Richter, L. Mutlu, F. Zipp, et al. 2005. Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. The FASEB Journal 19 (10): 1347–1349.

Article  CAS  PubMed  Google Scholar 

Dick, S.A., and S. Epelman. 2016. Chronic heart failure and inflammation: What do we really know? Circulation Research 119 (1): 159–176.

Article  CAS  PubMed  Google Scholar 

Bracho-Sanchez, E., F.G. Rocha, S.K. Bedingfield, B.D. Partain, S.L. Macias, M.A. Brusko, et al. 2023. Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase. Nature Biomedical Engineering 7 (9): 1156–1169.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agus, A., K. Clement, and H. Sokol. 2021. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut 70 (6): 1174–1182.